Literature DB >> 27471002

BH3 profiling as a tool to identify acquired resistance to venetoclax in multiple myeloma.

Christelle Dousset1, Sophie Maïga1, Patricia Gomez-Bougie1, Joy Le Coq1, Cyrille Touzeau1, Philippe Moreau1, Steven Le Gouill1, David Chiron1, Catherine Pellat-Deceunynck1, Agnès Moreau-Aubry1, Martine Amiot1.   

Abstract

Entities:  

Keywords:  BCL2 family members; Venetoclax; apoptosis; resistance

Mesh：

Substances：

Year:  2016        PMID： 27471002     DOI： 10.1111/bjh.14251

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  10 in total

Review 1.  Pathways and mechanisms of venetoclax resistance.

Authors:  Prithviraj Bose; Varsha Gandhi; Marina Konopleva
Journal:  Leuk Lymphoma       Date:  2017-01-31

2.  p53 regulates CD46 expression and measles virus infection in myeloma cells.

Authors:  Anne Lok; Geraldine Descamps; Benoit Tessoulin; David Chiron; Marion Eveillard; Catherine Godon; Yannick Le Bris; Astrid Vabret; Celine Bellanger; Laurent Maillet; Sophie Barillé-Nion; Marc Gregoire; Jean-François Fonteneau; Steven Le Gouill; Philippe Moreau; Frederic Tangy; Martine Amiot; Agnes Moreau-Aubry; Catherine Pellat-Deceunynck
Journal:  Blood Adv       Date:  2018-12-11

3.  Preclinical evaluation of the simultaneous inhibition of MCL-1 and BCL-2 with the combination of S63845 and venetoclax in multiple myeloma.

Authors:  Esperanza M Algarín; Andrea Díaz-Tejedor; Pedro Mogollón; Susana Hernández-García; Luis A Corchete; Laura San-Segundo; Montserrat Martín-Sánchez; Lorena González-Méndez; Marie Schoumacher; Sebastien Banquet; Laurence Kraus-Berthier; Ioana Kloos; Alix Derreal; Ensar Halilovic; Heiko Maacke; Norma C Gutiérrez; María-Victoria Mateos; Teresa Paíno; Mercedes Garayoa; Enrique M Ocio
Journal:  Haematologica       Date:  2019-07-18       Impact factor: 9.941

Review 4.  Venetoclax-based therapies for acute myeloid leukemia.

Authors:  Veronica A Guerra; Courtney DiNardo; Marina Konopleva
Journal:  Best Pract Res Clin Haematol       Date:  2019-05-24       Impact factor: 3.020

5.  A Phase I/II Trial of Carfilzomib, Pegylated Liposomal Doxorubicin, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma.

Authors:  Mark A Schroeder; Mark A Fiala; Eric Huselton; Michael H Cardone; Savina Jaeger; Sae Rin Jean; Kathryn Shea; Armin Ghobadi; Tanya Wildes; Keith E Stockerl-Goldstein; Ravi Vij
Journal:  Clin Cancer Res       Date:  2019-04-05       Impact factor: 12.531

6.  Venetoclax Synergizes with Radiotherapy for Treatment of B-cell Lymphomas.

Authors:  Shyril O'Steen; Damian J Green; Ajay K Gopal; Johnnie J Orozco; Aimee L Kenoyer; Yukang Lin; D Scott Wilbur; Donald K Hamlin; Darrell R Fisher; Mark D Hylarides; Theodore A Gooley; Amelia Waltman; Brian G Till; Oliver W Press
Journal:  Cancer Res       Date:  2017-05-31       Impact factor: 12.701

7.  Venetoclax sensitivity in multiple myeloma is associated with B-cell gene expression.

Authors:  Vikas A Gupta; Benjamin G Barwick; Shannon M Matulis; Ryosuke Shirasaki; David L Jaye; Jonathan J Keats; Benjamin Oberlton; Nisha S Joseph; Craig C Hofmeister; Leonard T Heffner; Madhav V Dhodapkar; Ajay K Nooka; Sagar Lonial; Constantine S Mitsiades; Jonathan L Kaufman; Lawrence H Boise
Journal:  Blood       Date:  2021-07-01       Impact factor: 25.476

Review 8.  Updates in the Use of BCL-2-Family Small Molecule Inhibitors for the Treatment of Relapsed/Refractory Multiple Myeloma.

Authors:  Ricardo D Parrondo; Aneel Paulus; Sikander Ailawadhi
Journal:  Cancers (Basel)       Date:  2022-07-08       Impact factor: 6.575

Review 9.  Restoring Apoptosis with BH3 Mimetics in Mature B-Cell Malignancies.

Authors:  Maxime Jullien; Patricia Gomez-Bougie; David Chiron; Cyrille Touzeau
Journal:  Cells       Date:  2020-03-14       Impact factor: 6.600

10.  Heterogeneous modulation of Bcl-2 family members and drug efflux mediate MCL-1 inhibitor resistance in multiple myeloma.

Authors:  Arnold Bolomsky; Juho J Miettinen; Alina Malyutina; Andrej Besse; Julia Huber; Stefanie Fellinger; Helene Breid; Alun Parsons; Kristaps Klavins; J Thomas Hannich; Stefan Kubicek; Jo Caers; Wolfgang Hübl; Martin Schreder; Niklas Zojer; Christoph Driessen; Jing Tang; Lenka Besse; Caroline A Heckman; Heinz Ludwig
Journal:  Blood Adv       Date:  2021-10-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.